ESC Premium Access

National prevalence and outcomes of different mitral valve interventions for mitral regurgitation among patients with cardiogenic shock: an analysis of the national readmission database 2010-2018

Congress Presentation

About the speaker

Doctor Summer Aldrugh

University of Massachusetts, Worcester (United States of America)
0 follower

133 more presentations in this session

Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.

Speaker: Doctor M. Verdoia (Biella, IT)

Thumbnail

Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Thumbnail

Late outcomes of percutaneous coronary interventions (PCI) and subsequent life-quality in patients younger 40 years of age

Speaker: Professor F. Abdullayev (Baku, AZ)

Thumbnail

Rapid pacing is an independent predictor for high implantation depth using self-expandable devices in TAVR

Speaker: Assistant Professor V. Veulemans (Duesseldorf, DE)

Thumbnail

Influence of the speed of deflation of the stent delivery system in the myocardial blush and st-segment resolution in primary angioplasty: a randomized study

Speaker: Doctor I. Lozano Martinez-Luengas (Gijon, ES)

Thumbnail

Access the full session

Interventional Cardiology ePosters

Speakers: Doctor S. Aldrugh, Doctor M. Verdoia, Associate Professor D. Maximkin, Professor F. Abdullayev, Assistant Professor V. Veulemans...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Acute myocardial infarction with cardiogenic shock: how I did treat.

29 August 2021

ESC Premium Access

Prognostic significance of different congestion evaluation modalities in acute heart failure patients classified according to left ventricular ejection fraction

28 August 2021

ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk